FRANKFURT, Germany--(BUSINESS WIRE)--D A Prasanna, Chairman of Ecron Acunova CRO (EA), is pleased to announce the appointment of Anders Malm as Managing Director of Ecron Acunova GmbH, based in Frankfurt, Germany. Mr. Malm assumes the responsibility for operations of Europe and North America. He joins a management team consisting of Dr. Klaus Wiedey, Managing Director of EA Germany & CEO Europe and Mr. Klemens Schuette, Managing Director of New Business Opportunities.
Anders Malm joined Ecron Acunova in 2012 as Managing Director of Ecron Acunova A/S in Denmark with responsibility for the Nordic region. With his experience in managing an Oncology CRO in USA, he was made responsible for North American operation as CEO of Acunova Life Sciences, Inc. Princeton, NJ. With an M.Sc. from Cornell University and an MBA from Sweden, Anders Malm brings 25 years of business experience, with 15 years in the CRO sector on both sides of Atlantic.
Speaking on the appointment, D A Prasanna said, “Mr. Malm brings extensive professional experience in clinical research services and network of customer relationship in Europe and US. With his experience, he will grow and transform Ecron Acunova services to effectively meet the changing needs of sponsors”.
On his appointment, Mr. Malm said, “Ecron Acunova is a CRO with rich experience and potential. With a highly trained staff in three continents Ecron Acunova has a knowledge base which is unique for a CRO of our size. The company has a global reach, while at the same time we are small enough to take care of clients on a local basis. We will continue to serve existing clients and build close relations with Biotech and smaller Pharmaceutical companies for global as well as local services. It is a pleasure and privilege for me to be part of the leadership team of Ecron Acunova”.
Ecron Acunova (www.ecronacunova.com ) is an expert CRO with over 25 years of track record with direct presence in 19 European countries 9 Asian countries in addition to US/Canada. It offers full-service clinical research including clinical operations, data management, biostatistics, pharmacovigilance, PK/PD services and central lab to pharma, biotech, medical device, nutrition and diagnostic companies. EA operates each region as a priority market with European HQ in Frankfurt, Asian HQ at Singapore, and US HQ at Princeton. With a team of over 350 professionals including 76 MDs, PhDs, Econ Acunova is reputed to accelerate pharma time-to-market cost effectively.